Delivery Order SPE2DB22D2206-SPE2DB23FJB28
Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $741
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,787.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561730831 VALGANCICLOVIR HCL 50 MG/ML 88ML. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the pharmaceutical product from its facility in Conshohocken, Pennsylvania under a one-day period of performance beginning and ending on August 7-8, 2023. As a key distributor supporting the Department of Defense's medical supply chain,...
- The Defense Logistics Agency awarded a $370,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561731920 valganciclovir hydrochloride 50 mg/ml 88ml. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 8, 2023 to support the Defense Logistics Agency's supply chain and logistics programs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $707.98 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561626221 valganciclovir 450 mg tablets in quantities of 60 tablets. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 27, 2023 through July 28, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- The Defense Logistics Agency awarded a delivery order valued at $3,331.00 to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml in an 88 ml formulation, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the awardee's facility in Conshohocken, Pennsylvania. The order represents a single delivery task under AmerisourceBergen's larger relationship with the federal government's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Valganciclovir HCL 50 mg/ml (88 ml) on August 11, 2025, with a ceiling value of $1,024.62. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and represents a non-competitive set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $4,120.32 to AmerisourceBergen Drug Corp for the supply of Valganciclovir HCL 50 mg/ml in an 88ml formulation. This is a firm fixed price, non-set-aside delivery order with a completion date of September 11, 2025, issued on September 10, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,000 to Amerisourcebergen Drug Corporation to supply 450 mg valganciclovir tablets. As the prime contractor, Amerisourcebergen will deliver 60 tablets to a facility in Conshohocken, Pennsylvania, under a single-day performance period from July 20 through July 21, 2023. The Defense Logistics Agency routinely utilizes indefinite-delivery/indefinite-quantity contracts to support the medical readiness of...
- The Defense Logistics Agency awarded a $818.59 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562203978 VALGANCICLOVIR HCL 50 MG/ML 88ML. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility under the terms of the order, which runs from September 17-18, 2023. As the DLA supports military readiness through logistics solutions, this small order was likely placed to support treatment of service members and their...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $12,511.52 firm fixed price delivery order from the Defense Logistics Agency (DLA) to supply 450 mg valganciclovir tablets. As the prime contractor, Amerisourcebergen will deliver 60 tablets to support DLA Troop Support Medical programs. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by December 13, 2023. No set-aside designation was applied to this award made...
- The Defense Logistics Agency awarded a $4,048.61 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Valganciclovir 450 mg tablets in unit dose packaging of 20s. This is a firm fixed price, competitively awarded contract with no set-aside designation and a performance location in Conshohocken, Pennsylvania. The delivery order is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB23FJB28Delivery Order
The Defense Logistics Agency awarded a $741 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561431533 VALGANCICLOVIR HCL 50 MG/ML 88ML. The prime contractor will deliver the pharmaceutical product from its Conshohocken, Pennsylvania facility by July 10, 2023 to support the Defense Logistics Agency's mission of providing logistics support to the Department of Defense. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform the contract without the use of major subcontractors.
Generated 12/20/23, 5:10 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $741 | 7/7/23 |